rs133290
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004599.4(SREBF2):c.867+566C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.606 in 151,998 control chromosomes in the GnomAD database, including 29,567 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004599.4 intron
Scores
Clinical Significance
Conservation
Publications
- neurocutaneous syndromeInheritance: AD Classification: MODERATE Submitted by: PanelApp Australia
- multiple congenital anomalies/dysmorphic syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary spastic paraplegiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004599.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.605 AC: 91940AN: 151880Hom.: 29517 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.606 AC: 92042AN: 151998Hom.: 29567 Cov.: 32 AF XY: 0.602 AC XY: 44747AN XY: 74310 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.